Home  »  News   »  Biora Therapeutics Inc. (BIOR): Investing has neve...

Biora Therapeutics Inc. (BIOR): Investing has never been easier

At the end of the latest market close, Biora Therapeutics Inc. (BIOR) was valued at $0.75. In that particular session, Stock kicked-off at the price of $0.7013 while reaching the peak value of $0.7699 and lowest value recorded on the day was $0.69. The stock current value is $0.79.Recently in News on August 3, 2022, Biora Therapeutics Announces Five Abstracts Accepted at American College of Gastroenterology Annual Scientific Meeting 2022. Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company that is reimagining therapeutics, today announced the acceptance of five abstracts for presentation at the American College of Gastroenterology (ACG) 2022 Annual Scientific Meeting. ACG’s mission is to advance world-class care for patients with gastrointestinal disorders through excellence, innovation, and advocacy in the areas of scientific investigation, education, prevention, and treatment. The 2022 ACG Annual Scientific Meeting will be held in Charlotte, NC and virtually from October 21–26, 2022. You can read further details here

Biora Therapeutics Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $2.3100 on 01/04/22, with the lowest value was $0.5600 for the same time period, recorded on 06/14/22.

Top 5 Cheap Stocks to Own Right Now

While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.

Sign up here to get your free report now. .


Biora Therapeutics Inc. (BIOR) full year performance was -60.11%

Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Biora Therapeutics Inc. shares are logging -87.30% during the 52-week period from high price, and 40.55% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $0.56 and $6.20.

The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 640045 for the day, which was evidently lower, when compared to the average daily volumes of the shares.

When it comes to the year-to-date metrics, the Biora Therapeutics Inc. (BIOR) recorded performance in the market was -64.11%, having the revenues showcasing -23.02% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 132.85M, as it employees total of 124 workers.

Market experts do have their say about Biora Therapeutics Inc. (BIOR)

During the last month, 0 analysts gave the Biora Therapeutics Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.

According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 0.8822, with a change in the price was noted -0.32. In a similar fashion, Biora Therapeutics Inc. posted a movement of -28.38% for the period of last 100 days, recording 3,802,400 in trading volumes.

Technical breakdown of Biora Therapeutics Inc. (BIOR)

Raw Stochastic average of Biora Therapeutics Inc. in the period of last 50 days is set at 76.10%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 97.21%. In the last 20 days, the company’s Stochastic %K was 81.29% and its Stochastic %D was recorded 69.62%.

Bearing in mind the latest performance of Biora Therapeutics Inc., several moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -64.11%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -50.00%, alongside a downfall of -60.11% for the period of the last 12 months. The shares increased approximately by 4.63% in the 7-day charts and went down by 18.88% in the period of the last 30 days. Common stock shares were lifted by -23.02% during last recorded quarter.

Leave a Comment

Your email address will not be published.

On Key

Related Posts